熱門資訊> 正文

Insight分子诊断公司2025年第四季度盈利预览

2026-03-26 05:35

Insight Molecular Diagnostics Inc.(IMDX) 0

Insight Molecular Diagnostics Inc. (IMDX) is scheduled to announce Q4 earnings results on Thursday, March 26th, after market close.
The consensus EPS estimate is -$0.24, and the consensus revenue estimate is $0.28M (-81.2% Y/Y).
Over the last 1 year, IMDX has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time.

More on Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics prices $26M registered direct offering; shares down
Seeking Alpha’s Quant Rating on Insight Molecular Diagnostics Inc.
Historical earnings data for Insight Molecular Diagnostics Inc.
Financial information for Insight Molecular Diagnostics Inc.

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。